ERCC2 and neutropenia: Finally, with respect to the excision repair genes, previous studies reported a correlation between severe neutropenia and the rs1799793 (934G > A) variant A-allele in ERCC2 in 104 ovarian cancer patients receiving a cisplatin-cyclophosphamide regimen [32].